Cypress Wealth Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-35,308
Closed -$1.23M – 444
2020
Q3
$1.23M Buy
+35,308
New +$1.24M 0.31% 66

Other funds holding PFE

Cypress Wealth Services's PFE Position: Q3 2026 in Review

Cypress Wealth Services reduced its Pfizer (PFE) stake by 2.8% in Q3 2026, selling an estimated $14K and leaving 18,546 shares worth $510K. The position accounts for 0.06% of the portfolio, ranked #235.

Cypress Wealth Services first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.28M in Q4 2020. 2,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Cypress Wealth Services held 18,546 shares of Pfizer worth $510K as of Q3 2026.
  • Cypress Wealth Services sold 528 Pfizer shares in Q3 2026, an estimated $14K.
  • Pfizer made up 0.06% of Cypress Wealth Services's portfolio in Q3 2026, its #235 holding.
  • Cypress Wealth Services first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
  • Cypress Wealth Services's Pfizer position peaked at $1.28M in Q4 2020.
  • 2,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Cypress Wealth Services's 13F filing for Q3 2026, filed 21 Oct 2026.